PF-562271 (Standard)
PF-562271 (Standard) (VS-6062 (Standard)) is the analytical standard of PF-562271 (HY-10459). This product is intended for research and analytical applications. PF-562271 (VS-6062) is an orally active, ATP-competitive, reversible FAK/Pyk2 inhibitor, with an IC50 of 1.5 nM for FAK and 13 nM for Pyk2. PF-562271 induces tumor regression, and inhibits tumor growth, invasion and metastasis. PF-562271 exerts no effect on tumor necrosis, angiogenesis or apoptosis in an orthotopic mouse model of pancreatic ductal adenocarcinoma. When combined with Sunitinib (HY-10255A), PF-562271 reduces tumor vascularization, decreases serum alpha-fetoprotein levels and improves cachexia. PF-562271 can be used in research related to prostate cancer, breast cancer, pancreatic cancer, colon cancer, glioblastoma, lung cancer, pancreatic ductal adenocarcinoma and hepatocellular carcinoma.
For research use only. We do not sell to patients.
- Purity : 95%
- CAS No.: 717907-75-0
- Formula: C21H20F3N7O3S
- Molecular Weight:507.49
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Product Details
-
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 717907-75-0
-
Molecular Weight 507.49
-
Formula C21H20F3N7O3S
-
SMILES
CS(=O)(N(C)C1=NC=CC=C1CNC2=NC(NC3=CC4=C(C=C3)NC(C4)=O)=NC=C2C(F)(F)F)=O
-
Synonyms
VS-6062 (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- PF-562271 (Standard)
- 717907-75-0
- VS-6062 (Standard)
- Reference Standards
- FAK
- Pyk2
- PTK2 protein tyrosine kinase 2
- PTK2
- Focal adhesion kinase
- Proline-rich tyrosine kinase 2
- tyrosine kinase
- prostate cancer
- MAD08-608 human PDA cell line
- breast cancer
- PC-3M human prostate cancer cell
- A431 epithelial carcinoma cells
- pancreatic ductal adenocarcinoma
- MPanc-96 human PDA cell line
- Inhibitor
- inhibitor
- inhibit